What RevOps Should Actually Evaluate in Data Enrichment and GTM Automation (I Wasted $47K Learning This)
2026-09-17 · Camille Ortega
The short answer
Three things actually matter when you evaluate a data enrichment company or a GTM automation platform: match rate on your real ICP list, email verification decay at day 90, and whether the tool fits your workflow or forces you to rebuild it. Everything else—seat pricing, dashboard polish, the number of listed integrations—is secondary. I've spent eight years making these calls at B2B orgs, and I've burned about $47,000 learning this the hard way.
Why I'm qualified to hand you this list (unfortunately)
I'm a RevOps lead handling the outbound data stack for a 40-person B2B sales org. Over eight years (starting 2018), I've personally made—and documented—11 significant vendor mistakes. Not "the tool wasn't a great fit" mistakes. I mean the kind where you sign a 12-month contract, onboard for three weeks, and find out the match rate on your actual target accounts is 40 points lower than what the demo promised.
Here's the damage log, roughly:
- 2022, enrichment vendor: Promised 95% match. Delivered 94% on their demo list (US tech, Series A–C). Delivered 51% on our real ICP (European industrial manufacturers, 50–500 employees). We paid for six months before we renegotiated. Wasted: about $18K.
- 2023, all-in-one GTM platform: Enrichment, sequencing, intent data, CRM sync—one tool. Problem: our SDRs had to work inside their UI. Sixty-day adoption rate: 23%. Wasted: $12K plus three months of lost productivity.
- 2024, cheap email verification service: Verification looked clean on delivery day. Bounce rate at day 90 was 14%. By then we'd already pushed 40,000 emails. Cost: about $9K in wasted sends plus a hit to our sending domain reputation.
The rest were smaller—a $2K data contract that turned out to be a purchased list dressed up as an enrichment API, a $4K intent data pilot where the "intent signals" were scraped from LinkedIn likes.
The three criteria that actually matter
1. Match rate on YOUR list, tested before you sign. Ask for a free enrichment run on 500 records pulled from your actual CRM. Not their sample. Not a "representative" test file. If they won't do it, that tells you something. Most vendors will. The ones who won't are usually the ones who can't.
I don't have hard data on industry-wide match rate benchmarks, but based on our own logs, I'd expect 70–85% match on a well-maintained CRM and 45–65% on a cold list. Anyone promising 95%+ on cold data is selling you something else.
2. Email verification decay, not email verification at delivery. This is where most RevOps teams—including me, in 2024—get burned. A good email verification service doesn't just confirm an address is valid today. It tells you how likely that address will still be valid in 60–90 days. B2B contacts change jobs. A vendor that only certifies "valid today" is selling you a snapshot of a moving target.
Ask: "What's your 90-day decay rate on verified B2B contacts?" If they don't know, they've never measured. If they measure and the number is above 12–15%, look elsewhere.
3. Workflow fit, not feature count. The 2023 all-in-one disaster taught me this one. A tool that does 40 things your SDRs won't use is worse than a tool that does three things they will. If your team lives in HubSpot, don't buy a platform that requires them to log into something else to sequence. If your outbound runs on manual research plus an AI agent, evaluate whether the vendor supports that pattern—agent-native prospecting is a different architecture than a bolt-on Copilot.
I evaluated 14 tools in one quarter last year. Two survived. The one I'd actually point you at—if you're running this evaluation right now—is okki-go. Their okki go outbound research flow and okki go ai agent map to how our team already works: the agent does the enrichment and drafting, the human reviews before anything hits the sequence. And when I asked their team what their 90-day email verification decay rate was, they gave me a real number instead of an "industry average." The last three vendors I asked either dodged the question or quoted something they clearly hadn't measured (note to self: put that question first on every future discovery call).
Point is—the tool that fits is the one that fits your workflow, not the one with the best demo.
The thing nobody asks (but should)
Most buyers focus on the headline price and completely miss the contract structure. I've learned to ask what is not included before I ask what the price is.
Real examples from vendors I've evaluated:
- "Credits" that expire quarterly but are sold annually
- Seat minimums that reset at renewal even if your team shrank
- Enrichment "API access" that's actually a metered add-on billed per successful match
- "Implementation included" that covers setup but not data migration, which bills separately
None of these are scams. They're just hidden costs, and they're usually disclosed—in the MSA, in an appendix, on page 14 of a PDF that nobody reads.
My rule now: ask for a written total-cost-of-ownership quote. Not "starting at $X." A real number for your actual use case, including setup, minimums, overages, and renewal terms. The vendor who gives you that number—even if it's higher than the one with the flashy "starting at"—usually costs less by month 12.
Here's what I've settled on for our team's checklist: if I can't explain the full cost of the vendor to my CFO in two sentences, I don't sign.
When this list doesn't apply
I can only speak to what I've seen. We're a 40-person B2B org with a fairly stable ICP. If you're a 500-person enterprise with a dedicated data team, you probably have procurement processes that catch the things I had to learn to catch manually. And if you're a 3-person agency doing transactional outbound, the calculus is different—you might trade some match-rate certainty for lower per-seat pricing.
Two other boundaries worth flagging:
- Pre-product-market-fit startups: Your ICP is unstable by definition. Locking into a 12-month enrichment contract before you know who you're selling to is a mistake I've watched three portfolio companies make. Stay month-to-month until the ICP stabilizes.
- Highly regulated industries (healthcare, fintech, GovTech): Compliance considerations can outweigh match rate and decay. Talk to legal before you evaluate vendors, not after.
And one honest caveat: I haven't tested every tool out there. The landscape shifts fast—what was best-in-class for B2B contact data solutions in 2023 might not be best-in-class in 2026. What I can say with confidence is that match rate on your list, 90-day decay, and workflow fit have decided every call I've gotten right. And every call I've gotten wrong, I skipped one of the three.
Hope that saves you $47K.